Epivir ratings & reviews

Lamivudine
Company: 
Brand: Epivir
Drug class: General Anti-infectives Systemic
+3 more
General Anti-infectives Systemic, Antivirals For Systemic Use, HIV Antivirals, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)s
Overall rating
3.8
full star full star full star half star empty star
Ranked #4
Physician ratings
  • Efficacy: effective for its intended use
  • Safety: safe to use in humans
  • Tolerability: low drug side effects
  • Accessibility: insurance/payer coverage, cost, affordability,formulary coverage, availability in your hospital or practice setting
  • Adherence: patient compliance with treatment
Efficacy
4.0/5
Safety
3.8/5
Tolerability
3.7/5
Accessibility
3.7/5
Adherence
3.6/5

Sermo AI Overview

  • Epivir is broadly regarded as an effective treatment for both HIV and hepatitis B, particularly for patients who cannot use other medications like tenofovir. Physicians often highlight its efficacy and tolerability in managing these conditions.
  • While many patients and clinicians find Epivir effective, adherence can be variable, with some facing challenges related to tolerability and accessibility, impacting long-term use and patient experiences.
  • Concerns have been raised about the tolerability of Epivir, as some patients report difficulties that can affect their ongoing treatment, leading to mixed feelings among healthcare providers regarding its long-term use.
  • Some specialists express mixed reviews regarding Epivir's efficacy compared to newer hepatitis B treatments, suggesting that while it is a good option, advancements in therapy may provide better results for certain patients.
  • Was this summary helpful?
Based on insights from Sermo’s triple verified physicians

Description

Epivir contains the active ingredient lamivudine, which is a synthetic nucleoside analogue. It is available in tablet form for oral administration, with dosage strengths of 150 mg and 300 mg per tablet. Key inactive ingredients include microcrystalline cellulose, sodium starch glycolate, and povidone. Lamivudine is designed to have activity against HIV-1 and HBV.

Source: This information is sourced from FDA and powered by AI

Dosage & Administration

How should I use this medication?

Take this medication by mouth with water. Use a specially marked oral syringe, spoon, or dropper to measure each dose. Ask your pharmacist if you do not have one. Household spoons are not accurate. You can take this medication with or without food. If it upsets your stomach, take it with food. For your therapy to work as well as possible, take each dose exactly as prescribed on the prescription label. Do not skip doses. Skipping doses can make the HIV virus resistant to this medication and other medications. Keep taking this therapy unless your care team tells you to stop.

Talk to your care team about the use of this medication in children. While this medication may be prescribed for children as young as 3 months old for selected conditions, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once.

NOTE: This medicine is only for you. Do not share this medicine with others.

What if I miss a dose?

If you miss a dose, take it as soon as you can. If it is almost time for your next dose, take only that dose. Do not take double or extra doses.

Where should I keep my medication?

Keep out of the reach of children and pets.

Store at a room temperature of 20 to 25 degrees C (68 to 77 degrees F). Get rid of any unused medication after the expiration date.To get rid of medications that are no longer wanted or have expired:

  • Take the medication to a medication take-back program. Check with your pharmacy or law enforcement to find a location.
  • If you cannot return the medication, check the label or package insert to see if the medication should be thrown out in the garbage or flushed down the toilet. If you are not sure, ask your care team. If it is safe to put it in the trash, empty the medication out of the container. Mix the medication with cat litter, dirt, coffee grounds, or other unwanted substances. Seal the mixture in a bag or container. Put it in the trash.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

Side Effects

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • High lactic acid level—muscle pain or cramps, stomach pain, trouble breathing, general discomfort and fatigue
  • Liver injury—right upper belly pain, loss of appetite, nausea, light-colored stool, dark yellow or brown urine, yellowing skin or eyes, unusual weakness or fatigue
  • Pancreatitis—severe stomach pain that spreads to your back or gets worse after eating or when touched, fever, nausea, vomiting

Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):

  • Cough
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Nausea
  • Runny or stuffy nose

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings & Precautions

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

  • Diabetes
  • Frequently drink alcohol
  • Kidney disease
  • Liver disease
  • Pancreatitis
  • An unusual or allergic reaction to lamivudine, other medications, foods, dyes, or preservatives
  • Pregnant or trying to get pregnant
  • Breast-feeding

What may interact with this medication?

  • Emtricitabine
  • Interferon
  • Other lamivudine medications
  • Ribavirin
  • Sorbitol-containing medications

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What should I watch for while using this medication?

Visit your care team for regular checks on your progress. Tell your care team if your symptoms get worse or if you have new symptoms.

You may need blood work done while you are taking this medication.

HIV is spread to others through sexual or blood contact. Talk to your care team about how to stop the spread of HIV.

Do not stop taking this medication without first talking to your care team. If you have HIV and hepatitis B, the symptoms of hepatitis B may worsen when you stop taking this medication. Your care team will check your liver and general health for several months after treatment is stopped.

Make sure you have the correct formulation of this medication. The products used to help manage HIV symptoms contain a higher dose of lamivudine than the products used to treat hepatitis B. It is important that you take the right dose. If you have both HIV and hepatitis B, you need to take the product for HIV. Taking the wrong dose can make HIV change, which can cause the medication to not work as well. This makes it hard to stay healthy.

What are the most serious risks of this medication?

Make sure you have the correct formulation of this medication. The products used to help manage HIV symptoms contain a higher dose of lamivudine than the products used to treat hepatitis B. It is important that you take the right dose. If you have both HIV and hepatitis B, you need to take the product for HIV. Taking the wrong dose can make HIV change, which can cause the medication to not work as well. This makes it hard to stay healthy.

Do not stop taking this medication without first talking to your care team. If you have both HIV and hepatitis B, the symptoms of hepatitis B may worsen when you stop taking this medication. Your care team will check your liver and general health after treatment is stopped. You may need to take other medications if your hepatitis flares or returns.

Source: This information is sourced from Elsevier Inc.

Disclaimer

The reviews, ratings, comments, and opinions expressed on this platform are solely those of the individual medical professionals who posted them and do not reflect the views or positions of Sermo, Inc. Sermo does not endorse, verify, or validate the content of individual reviews. The information provided is user-generated and reflects personal clinical experiences, which may not be complete, accurate, or applicable to your specific health needs. It is not intended as medical advice.

Prescription medications affect individuals differently, and what works for one person may not work for another. Always consult your doctor, pharmacist, or other qualified healthcare provider to ensure the information displayed applies to your personal circumstances. Only a licensed healthcare provider can advise you on what is safe and effective for you.

Keep all medications out of the reach of children, never share your medicine with others, and use each medication only as prescribed. Your reliance on any information provided on this platform is at your own risk.

Terms of use

  1. Sermo Drug Ratings, and all information provided on this website, may not be used in combination with any artificial intelligence tool (including to train an algorithm, test, process, analyze, generate output and/or develop any form of artificial intelligence tool). 

  2. Visitors to the online patient-facing website at Sermo.com (“Sermo Drug Ratings”) are Authorized Users of the website, which contains data owned by a third-party provider, Elsevier, Inc.  Accordingly, by visiting Sermo Drug Ratings, Authorized User acknowledges that the website includes Elsevier owned data that Sermo licenses pursuant to a separate usage and Data agreement (the “Agreements”).  Authorized User further acknowledges that Sermo is a third-party beneficiary of the Agreements and Authorized User’s use of the website hereby binds them to the terms of the Agreements; provided, however, that Elsevier shall have no obligations or liability to an Authorized User whatsoever pursuant to the terms of the Agreements.

  3. Authorized User acknowledges and agrees that the Elsevier Products are designed for and are intended to be used by those residing in the United States, and that the information contained in the Elsevier Products does not comply with any laws or practices outside of the United States. You assume all responsibilities, duties, and obligations for any treatment, decision, or advice made or given to third parties as a result of the use or application of the Elsevier Products outside of the United States, and Sermo, Elsevier and its affiliates, subsidiaries, agents and suppliers will incur no liability for any use or application of the Products by Authorized Users outside of the United States.

Welcome to Sermo's Drug Ratings

Previously only for members, Sermo Drug Ratings are now openly available to all healthcare providers, patients, and industry professionals to support better healthcare decisions.

Clinical expertise
Insights based on real prescribing experience from triple-verified practicing physicians only
Detailed insights
Ratings on key attributes including efficacy, safety, tolerability, accessibility, and adherence
Unbiased reviews
Independent, physician-only reviews, free from pharmaceutical industry influence